Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of invasive fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.06602341186266347 | N/A |
Market Cap | $3.35M | N/A |
Shares Outstanding | 50.69M | N/A |
Employees | 4.00 | N/A |